Global Precision Oncology Market Overview:
Global Precision Oncology Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Precision Oncology Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Precision Oncology involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Precision Oncology Market:
The Precision Oncology Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Precision Oncology Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Precision Oncology Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Precision Oncology market has been segmented into:
Diagnostics and Therapeutics
By Application, Precision Oncology market has been segmented into:
Breast Cancer
Lung Cancer
Colorectal Cancer
Skin Cancer
Prostate Cancer
Stomach Cancer and Other
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Precision Oncology market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Precision Oncology market.
Top Key Players Covered in Precision Oncology market are:
Roche
Illumina
Inc.
Thermo Fisher Scientific Inc.
Qiagen N.V.
Agilent Technologies
Inc.
Foundation Medicine
Inc.
Guardant Health
Inc.
Myriad Genetics
Inc.
NanoString Technologies
Inc.
Exact Sciences Corporation
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Precision Oncology Market Type
4.1 Precision Oncology Market Snapshot and Growth Engine
4.2 Precision Oncology Market Overview
4.3 Diagnostics and Therapeutics
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Diagnostics and Therapeutics: Geographic Segmentation Analysis
Chapter 5: Precision Oncology Market Application
5.1 Precision Oncology Market Snapshot and Growth Engine
5.2 Precision Oncology Market Overview
5.3 Breast Cancer
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Breast Cancer: Geographic Segmentation Analysis
5.4 Lung Cancer
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Lung Cancer: Geographic Segmentation Analysis
5.5 Colorectal Cancer
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Colorectal Cancer: Geographic Segmentation Analysis
5.6 Skin Cancer
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Skin Cancer: Geographic Segmentation Analysis
5.7 Prostate Cancer
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Prostate Cancer: Geographic Segmentation Analysis
5.8 Stomach Cancer and Other
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Stomach Cancer and Other: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Precision Oncology Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ROCHE
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 ILLUMINA
6.4 INC.
6.5 THERMO FISHER SCIENTIFIC INC.
6.6 QIAGEN N.V.
6.7 AGILENT TECHNOLOGIES
6.8 INC.
6.9 FOUNDATION MEDICINE
6.10 INC.
6.11 GUARDANT HEALTH
6.12 INC.
6.13 MYRIAD GENETICS
6.14 INC.
6.15 NANOSTRING TECHNOLOGIES
6.16 INC.
6.17 EXACT SCIENCES CORPORATION
Chapter 7: Global Precision Oncology Market By Region
7.1 Overview
7.2. North America Precision Oncology Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Diagnostics and Therapeutics
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Breast Cancer
7.2.3.2 Lung Cancer
7.2.3.3 Colorectal Cancer
7.2.3.4 Skin Cancer
7.2.3.5 Prostate Cancer
7.2.3.6 Stomach Cancer and Other
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Precision Oncology Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Diagnostics and Therapeutics
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Breast Cancer
7.3.3.2 Lung Cancer
7.3.3.3 Colorectal Cancer
7.3.3.4 Skin Cancer
7.3.3.5 Prostate Cancer
7.3.3.6 Stomach Cancer and Other
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Precision Oncology Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Diagnostics and Therapeutics
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Breast Cancer
7.4.3.2 Lung Cancer
7.4.3.3 Colorectal Cancer
7.4.3.4 Skin Cancer
7.4.3.5 Prostate Cancer
7.4.3.6 Stomach Cancer and Other
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Precision Oncology Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Diagnostics and Therapeutics
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Breast Cancer
7.5.3.2 Lung Cancer
7.5.3.3 Colorectal Cancer
7.5.3.4 Skin Cancer
7.5.3.5 Prostate Cancer
7.5.3.6 Stomach Cancer and Other
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Precision Oncology Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Diagnostics and Therapeutics
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Breast Cancer
7.6.3.2 Lung Cancer
7.6.3.3 Colorectal Cancer
7.6.3.4 Skin Cancer
7.6.3.5 Prostate Cancer
7.6.3.6 Stomach Cancer and Other
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Precision Oncology Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Diagnostics and Therapeutics
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Breast Cancer
7.7.3.2 Lung Cancer
7.7.3.3 Colorectal Cancer
7.7.3.4 Skin Cancer
7.7.3.5 Prostate Cancer
7.7.3.6 Stomach Cancer and Other
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Precision Oncology Scope:
|
Report Data
|
Precision Oncology Market
|
|
Precision Oncology Market Size in 2025
|
USD XX million
|
|
Precision Oncology CAGR 2025 - 2032
|
XX%
|
|
Precision Oncology Base Year
|
2024
|
|
Precision Oncology Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Roche, Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Agilent Technologies, Inc., Foundation Medicine, Inc., Guardant Health, Inc., Myriad Genetics, Inc., NanoString Technologies, Inc., Exact Sciences Corporation.
|
|
Key Segments
|
By Type
Diagnostics and Therapeutics
By Applications
Breast Cancer
Lung Cancer
Colorectal Cancer
Skin Cancer
Prostate Cancer
Stomach Cancer and Other
|
